Fu­eled with a fresh half-bil­lion dol­lars as AI in­vest­ments boom, Ex­sci­en­tia is hit­ting the gas on drug de­vel­op­ment

Can AI rev­o­lu­tion­ize the way new drugs are found and de­vel­oped? For Ex­sci­en­tia, that’s now the half-bil­lion-dol­lar ques­tion.

It hasn’t been two months since Ex­sci­en­tia …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.